197 related articles for article (PubMed ID: 38290972)
1. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
[TBL] [Abstract][Full Text] [Related]
2. Novel exosomal circEGFR facilitates triple negative breast cancer autophagy via promoting TFEB nuclear trafficking and modulating miR-224-5p/ATG13/ULK1 feedback loop.
Song H; Zhao Z; Ma L; Zhao W; Hu Y; Song Y
Oncogene; 2024 Mar; 43(11):821-836. PubMed ID: 38280941
[TBL] [Abstract][Full Text] [Related]
3. Identification of ANXA2 (annexin A2) as a specific bleomycin target to induce pulmonary fibrosis by impeding TFEB-mediated autophagic flux.
Wang K; Zhang T; Lei Y; Li X; Jiang J; Lan J; Liu Y; Chen H; Gao W; Xie N; Chen Q; Zhu X; Liu X; Xie K; Peng Y; Nice EC; Wu M; Huang C; Wei Y
Autophagy; 2018; 14(2):269-282. PubMed ID: 29172997
[TBL] [Abstract][Full Text] [Related]
4. Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis.
Chaudhary P; Gibbs LD; Maji S; Lewis CM; Suzuki S; Vishwanatha JK
Breast Cancer Res; 2020 Jan; 22(1):11. PubMed ID: 31992335
[TBL] [Abstract][Full Text] [Related]
5. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
[TBL] [Abstract][Full Text] [Related]
6. Heat shock factor 1 (HSF1) controls chemoresistance and autophagy through transcriptional regulation of autophagy-related protein 7 (ATG7).
Desai S; Liu Z; Yao J; Patel N; Chen J; Wu Y; Ahn EE; Fodstad O; Tan M
J Biol Chem; 2013 Mar; 288(13):9165-76. PubMed ID: 23386620
[TBL] [Abstract][Full Text] [Related]
7. AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3.
Paquette M; El-Houjeiri L; C Zirden L; Puustinen P; Blanchette P; Jeong H; Dejgaard K; Siegel PM; Pause A
Autophagy; 2021 Dec; 17(12):3957-3975. PubMed ID: 33734022
[TBL] [Abstract][Full Text] [Related]
8. Nucleoporin TPR (translocated promoter region, nuclear basket protein) upregulation alters MTOR-HSF1 trails and suppresses autophagy induction in ependymoma.
Dewi FRP; Jiapaer S; Kobayashi A; Hazawa M; Ikliptikawati DK; Hartono ; Sabit H; Nakada M; Wong RW
Autophagy; 2021 Apr; 17(4):1001-1012. PubMed ID: 32207633
[TBL] [Abstract][Full Text] [Related]
9. ANXA2 could act as a moderator of EGFR-directed therapy resistance in triple negative breast cancer.
Zhang Y; Bi J; Zhu H; Shi M; Zeng X
Biosci Biotechnol Biochem; 2018 Oct; 82(10):1733-1741. PubMed ID: 29912633
[TBL] [Abstract][Full Text] [Related]
10. ANXA2 expression in African American triple-negative breast cancer patients.
Gibbs LD; Chaudhary P; Mansheim K; Hare RJ; Mantsch RA; Vishwanatha JK
Breast Cancer Res Treat; 2019 Feb; 174(1):113-120. PubMed ID: 30478786
[TBL] [Abstract][Full Text] [Related]
11. Important role of annexin A2 (ANXA2) in new blood vessel development in vivo and human triple negative breast cancer (TNBC) growth.
Sharma MC; Jain D
Exp Mol Pathol; 2020 Oct; 116():104523. PubMed ID: 32866522
[TBL] [Abstract][Full Text] [Related]
12. Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.
Viana PHL; Schvarcz CA; Danics LO; Besztercei B; Aloss K; Bokhari SMZ; Giunashvili N; Bócsi D; Koós Z; Benyó Z; Hamar P
Sci Rep; 2024 Apr; 14(1):8241. PubMed ID: 38589452
[TBL] [Abstract][Full Text] [Related]
13. MITF-MIR211 axis is a novel autophagy amplifier system during cellular stress.
Ozturk DG; Kocak M; Akcay A; Kinoglu K; Kara E; Buyuk Y; Kazan H; Gozuacik D
Autophagy; 2019 Mar; 15(3):375-390. PubMed ID: 30290719
[TBL] [Abstract][Full Text] [Related]
14. Mint3-depletion-induced energy stress sensitizes triple-negative breast cancer to chemotherapy via HSF1 inactivation.
Tanaka N; Okada H; Yamaguchi K; Seki M; Matsubara D; Gotoh N; Suzuki Y; Furukawa Y; Yamashita T; Inoue JI; Kaneko S; Sakamoto T
Cell Death Dis; 2023 Dec; 14(12):815. PubMed ID: 38081808
[TBL] [Abstract][Full Text] [Related]
15. Annexin A2 could enhance multidrug resistance by regulating NF-κB signaling pathway in pediatric neuroblastoma.
Wang Y; Chen K; Cai Y; Cai Y; Yuan X; Wang L; Wu Z; Wu Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):111. PubMed ID: 28814318
[TBL] [Abstract][Full Text] [Related]
16. Covalent JNK Inhibitor, JNK-IN-8, Suppresses Tumor Growth in Triple-Negative Breast Cancer by Activating TFEB- and TFE3-Mediated Lysosome Biogenesis and Autophagy.
Soleimani M; Somma A; Kaoud T; Goyal R; Bustamante J; Wylie DC; Holay N; Looney A; Giri U; Triplett T; Dalby K; Kowalski J; Eckhardt SG; Van Den Berg C
Mol Cancer Ther; 2022 Oct; 21(10):1547-1560. PubMed ID: 35977156
[TBL] [Abstract][Full Text] [Related]
17. TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression.
Zhang TM; Liao L; Yang SY; Huang MY; Zhang YL; Deng L; Hu SY; Yang F; Zhang FL; Shao ZM; Li DQ
Autophagy; 2023 Mar; 19(3):805-821. PubMed ID: 35920704
[TBL] [Abstract][Full Text] [Related]
18. The PI3K/mTOR dual inhibitor NVP-BEZ235 stimulates mutant p53 degradation to exert anti-tumor effects on triple-negative breast cancer cells.
Cai J; Xia J; Zou J; Wang Q; Ma Q; Sun R; Liao H; Xu L; Wang D; Guo X
FEBS Open Bio; 2020 Apr; 10(4):535-545. PubMed ID: 32027103
[TBL] [Abstract][Full Text] [Related]
19. 5α-Epoxyalantolactone Inhibits Metastasis of Triple-Negative Breast Cancer Cells by Covalently Binding a Conserved Cysteine of Annexin A2.
Wei M; Zhou Y; Li C; Yang Y; Liu T; Liu Y; Wei Y; Liu N; Liu S; Wang Q; Cao S; Sun Y; Sheng P; Lu C; Yang C; Liu X; Yang G
J Med Chem; 2021 Sep; 64(17):12537-12547. PubMed ID: 34351142
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of triple-negative and Herceptin-resistant breast cancer cell proliferation and migration by Annexin A2 antibodies.
Chaudhary P; Thamake SI; Shetty P; Vishwanatha JK
Br J Cancer; 2014 Dec; 111(12):2328-41. PubMed ID: 25321192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
